Seeking Alpha

Steven Breazzano

ABOUT
Steven currently focuses his analyses primarily on the valuation of smaller biotechs (100MM to 1 BB market cap) and utilizes all sources of information, including conversations with management, peer-reviewed publications, SEC filings, and all available primary and secondary research.

Steven is currently a consultant for a New York based Healthcare focused consultancy, and brings a strong scientific and financial background to his current position.

Previously, Steven earned a Ph.D. from the Scripps Research Institute and an M.A. from Columbia University, with extensive work in the field of synthetic and medicinal chemistry, publishing several papers in prestigious peer-reviewed journals. He is also ...More
SNAPSHOT
  • Description: Occasional Investor. Trading frequency: Monthly
  • Interests: Options, Stocks - long, Stocks - short
COMPANY
Currently, you have no company profile. Click edit to add a company profile.
BLOG
Currently, you have no blog details. Click edit to add blog details.
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success $RXDX http://seekingalpha.com/a/17s57 Feb 24, 2014